Oxford Global, Renaissance Tower Hotel Zurich, Switzerland
11th & 12th June 2012
Over 250 attendees Over 60 outstanding presentations / panel discussions 6 interactive streams: - Drug Discovery & Drug Development Strategies & Enabling Technologies
- Drug Development, Safety & Biomarkers
- Medicinal Chemistry / Drug Design
- Enabling Technologies and Screening
- Biologics & Antibodies
- Bioinformatics & Computational Biology
14 pre-scheduled one to one business meetings & exhibition Oxford Global Conferences are proud to present, as part of their key R&D Europe Series, the 13th Annual Drug Discovery & The Drug Development Leaders Summit, which will be held on the 11th-12th June 2012 at the Renaissance Tower Hotel, Zurich, Switzerland. The Summit is the single most, senior-level focused event in Europe dedicated to the drug discovery & drug development markets. It will also be co-located with our Clinical Trials Leaders Summit. (www.clinicaltrialseurope-summit.com) Over two days, the event will attract over 250 senior level decision makers from Europe, UK and the US with a comprehensive conference program featuring six separate streams, key note addresses, case study presentations and interactive panel discussions given by over 60 expert speakers from leading pharmaceutical, biotech, academic and research institutions. The Summit will address the current trends, strategies and business models in advancing R&D innovation whilst reducing attrition and costs through the entire discovery and development process. It will focus on the key topic areas in both large and small molecule R&D including Medicinal Chemistry, Screening, Assay Development and other Enabling Technologies, Biologics & Antibodies, Bioinformatics & Computational Biology as well as specific presentations on how the pharmaceutical sector is adjusting to the current international economic climate.
|
|